TOP TIERMARKET NEWSWIRE
Movers explained · 2026-10-06

Archived explainer. For the current picture see today's NVAX page.

Why Is NOVAVAX INC (NVAX) Stock Down Today?

By the Top Tier Newswire AI Desk · October 6, 2026 at 1:26 PM ET · reviewed against 6 wire stories

NOVAVAX INC (NVAX) is down -13.02% in the latest session. Our newswire has captured 6 stories on NVAX across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 55/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Why NVAX stock is down today

Novavax Inc (NASDAQ:NVAX) fell 13.02% to $10.93 in a single session, reversing a recent rally that had pushed the stock nearly 18% higher in the previous eight trading days. The decline followed a shift in sentiment as health officials downplayed the risk of a suspected pneumonic plague case in Russia, which had earlier triggered a surge in vaccine-related stocks. The stock opened at $12.50 and peaked at $13.33 before slipping to a session low of $10.92.

What Happened

The initial spike in Novavax shares had been driven by unconfirmed reports of a lab worker's death in Russia and speculation about increased demand for vaccines. However, as the World Health Organization and other health agencies described the risk as low, the market sentiment quickly reversed. This led to a broad cooling of enthusiasm for vaccine stocks, including Novavax and Moderna. In addition, Vaxcyte reported positive late-stage results for its pneumonia vaccine, drawing attention away from Novavax and contributing to the sell-off. The stock traded in a volatile range throughout the session, with volume reaching 12.6 million shares, more than double the 3-month average.

What The Data Shows

The stock has been highly volatile over the past year, trading between $6.20 and $13.38. The recent 52-week tape showed the stock printed one 52-week high and six 52-week lows on October 6, 2026. Unusual options activity in the last 36 hours included 29 notable prints, with $10.2 million in call premiums and $1.1 million in put premiums. The largest single options trade was for $1.5 million. These figures suggest heightened speculative interest but also underscore the stock's exposure to rapid sentiment shifts.

What To Watch

With no upcoming earnings date listed, the next key development for Novavax will likely be the breadth of coverage and market reaction to any new vaccine-related news or regulatory updates. Investors should monitor the company's partnership with Sanofi and any further developments in the Russian health situation for potential follow-through.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

NVAX by the numbers

Last: $10.93Session: -13.02%7 sessions: +6.49%Coverage: 6 stories / 4 sourcesAI sentiment: 55/100 (mixed)Mkt cap: $1.7B52w: $6.20 to $13.38
NVAX · Oct 6 session (5-min) · -9.95% vs prior close · updated 8:53 PM ET
$10.77$12.04$13.32prev close $12.56$11.317:00 AM10:13 AM1:27 PM4:41 PM7:55 PM7:00 AM · $12.407:05 AM · $12.437:10 AM · $12.577:15 AM · $12.607:20 AM · $12.597:25 AM · $12.547:30 AM · $12.697:35 AM · $12.627:40 AM · $12.607:45 AM · $12.657:50 AM · $12.607:55 AM · $12.438:00 AM · $12.548:05 AM · $12.458:10 AM · $12.458:15 AM · $12.428:20 AM · $12.248:25 AM · $12.148:30 AM · $12.148:35 AM · $12.228:40 AM · $12.278:45 AM · $12.038:50 AM · $12.088:55 AM · $12.119:00 AM · $12.109:05 AM · $12.029:10 AM · $12.049:15 AM · $12.139:20 AM · $12.149:25 AM · $12.289:30 AM · $12.299:35 AM · $12.909:40 AM · $13.199:45 AM · $12.639:50 AM · $12.519:55 AM · $12.2110:00 AM · $11.9710:05 AM · $11.5710:10 AM · $11.4410:15 AM · $11.1110:20 AM · $11.2210:25 AM · $11.3010:30 AM · $11.3510:35 AM · $11.2710:40 AM · $11.3810:45 AM · $11.3710:50 AM · $11.4310:55 AM · $11.4411:00 AM · $11.4511:05 AM · $11.5611:10 AM · $11.5011:15 AM · $11.5211:20 AM · $11.4211:25 AM · $11.4411:30 AM · $11.3811:35 AM · $11.3911:40 AM · $11.4011:45 AM · $11.4311:50 AM · $11.3611:55 AM · $11.2912:00 PM · $11.2212:05 PM · $11.1612:10 PM · $11.1612:15 PM · $11.1612:20 PM · $11.1512:25 PM · $11.1912:30 PM · $11.2012:35 PM · $11.2212:40 PM · $11.1812:45 PM · $11.2212:50 PM · $11.2112:55 PM · $11.201:00 PM · $11.211:05 PM · $11.171:10 PM · $11.141:15 PM · $11.131:20 PM · $10.941:25 PM · $10.971:30 PM · $10.941:35 PM · $10.901:40 PM · $10.981:45 PM · $10.971:50 PM · $10.941:55 PM · $10.912:00 PM · $10.902:05 PM · $10.912:10 PM · $10.952:15 PM · $10.952:20 PM · $11.022:25 PM · $11.062:30 PM · $11.062:35 PM · $11.062:40 PM · $11.042:45 PM · $11.092:50 PM · $11.062:55 PM · $11.143:00 PM · $11.113:05 PM · $11.123:10 PM · $11.133:15 PM · $11.133:20 PM · $11.113:25 PM · $11.073:30 PM · $11.053:35 PM · $11.023:40 PM · $11.023:45 PM · $11.043:50 PM · $11.223:55 PM · $11.314:00 PM · $11.274:05 PM · $11.324:10 PM · $11.314:15 PM · $11.314:20 PM · $11.214:30 PM · $11.324:35 PM · $11.304:40 PM · $11.304:45 PM · $11.344:50 PM · $11.305:00 PM · $11.315:05 PM · $11.305:10 PM · $11.305:15 PM · $11.325:20 PM · $11.305:25 PM · $11.325:30 PM · $11.375:35 PM · $11.375:40 PM · $11.365:45 PM · $11.365:55 PM · $11.376:00 PM · $11.316:10 PM · $11.306:20 PM · $11.306:25 PM · $11.306:30 PM · $11.356:35 PM · $11.316:40 PM · $11.306:45 PM · $11.326:50 PM · $11.306:55 PM · $11.327:05 PM · $11.337:15 PM · $11.307:25 PM · $11.307:40 PM · $11.337:45 PM · $11.317:50 PM · $11.317:55 PM · $11.31
AI sentiment, last 36h · averaged over 6 stories · 55/100 bullish
AI sentiment 55/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 6 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishInvesting.com Markets · sentiment 50 · Why is Novavax stock surging today?Investing.com Markets · 50Why is Novavax stock surging today?24/7 Wall St. · sentiment 67 · Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up24/7 Wall St. · 67Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%,…Stocktwits News · sentiment 67 · NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage TestStocktwits News · 67NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage TestStocktwits News · sentiment 58 · NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'Stocktwits News · 58NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'C…Seeking Alpha · sentiment 47 · Novavax, Moderna cool as WHO downplays plague-related death in RussiaSeeking Alpha · 47Novavax, Moderna cool as WHO downplays plague-related death in Russia24/7 Wall St. · sentiment 42 · Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher24/7 Wall St. · 42Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Hig…
45d ago24/7 Wall St.BEARISH 42General

Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher

A plague headline out of Siberia lifted vaccine stocks, and the agencies closest to the case have since described the risk as low. That reversal in sentiment lands hardest on Novavax (NASDAQ:NVAX), since the company’s rally priced a government-purchase scenario that its product line doesn’t address. Novavax stock trades at $12.32, down 2% in morning […]

45d agoSeeking AlphaNEUTRAL 47General

Novavax, Moderna cool as WHO downplays plague-related death in Russia

Novavax (NVAX) stock and Moderna (MRNA) stock trade flat after WHO updates on a suspected pneumonic plague death in Russia. Read more here.

45d agoStocktwits NewsBULLISH 58General

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

45d agoStocktwits NewsBULLISH 67Product/PR

NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test

Vaxcyte said earlier on Monday that its experimental pneumonia vaccine, VAX-31, met the main goals of a late-stage study in adults 50 and older.

45d ago24/7 Wall St.BULLISH 67Product/PR

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Sanofi is carrying the Nuvaxovid COVID-19 shot into the fall vaccination season, and buyers are rewarding shares of licensor Novavax (NASDAQ:NVAX) far more heavily than the rest of biotech. Novavax stock has rose 17% during afternoon trading, reaching $12.28, a move that stands well apart from its closest vaccine rivals and the broader sector. Checking […]

45d agoInvesting.com MarketsNEUTRAL 50General

Why is Novavax stock surging today?

Why is Novavax stock surging today?

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on NVAX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier NVAX move explainers: 2026-11-13 · 2026-11-12 · 2026-10-16 · 2026-10-09 · 2026-10-07 · 2026-10-06 · 2026-10-05 · 2026-09-10 · 2026-09-02 · 2026-09-01 · 2026-08-28